IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Novabay Pharmaceuticals Inc

CUSIP: 66987P201 | 71 institutional holders

Quarters

Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q1 2024

Nvwm, LLC86
0.0% of portfolio›$9
StyleTurnoverLocationFiled
Nvwm, LLC
86$90.0%GrowthMediumYardley, PA2024-05-07